BioAgilytix is a global contract research organization (CRO) specializing in bioanalytical testing services for the pharmaceutical and biotechnology industries. They focus on large molecule bioanalysis, supporting drug development from discovery through preclinical and clinical phases to post-market approval. Their expertise covers pharmacokinetics (PK), immunogenicity, biomarkers, and cell-based assays, operating under GxP (GLP, GCP, GMP) and non-GxP compliant environments. They are known for their scientific rigor, quality data, and collaborative approach to helping clients bring new therapies to market.
Serves as the central hub for global operations, strategic leadership, business development, and houses advanced bioanalytical laboratory facilities for North American clients.
State-of-the-art laboratory facilities equipped with cutting-edge bioanalytical instrumentation, designed for high-throughput sample analysis and complex assay development. Proximity to major academic institutions and biotech companies in RTP.
A science-driven, collaborative, and quality-focused environment. Employees are highly skilled scientists and technicians dedicated to advancing drug development. Emphasis on continuous learning and adherence to rigorous regulatory standards.
Its location in Research Triangle Park provides access to a rich talent pool, fosters collaborations with academic and industry partners, and positions BioAgilytix at the forefront of bioanalytical innovation.
BioAgilytix supports global drug development programs through its strategically located, GxP-compliant laboratories in North America (USA - North Carolina, Massachusetts, California), Europe (Germany), and Australia (South Australia, Queensland). These sites offer harmonized bioanalytical services, including assay development, validation, and sample analysis for pharmacokinetics (PK), immunogenicity, biomarkers, and cell-based assays, enabling seamless support for multinational clinical trials and regulatory submissions across different regions.
2300 Englert Drive
Durham
North Carolina
USA
Address: Lise-Meitner-Strasse 8, 22926 Ahrensburg, Germany
Supports drug development programs throughout Europe, ensuring compliance with EMA and other regional regulatory standards. Facilitates access to European markets and research collaborations.
Address: 132 Artino St, Oberlin, OH 44074, USA (Note: This listed address seems to be for a previous acquisition, MilliporeSigma's BioReliance bioanalytical labs in Boston. BioAgilytix has a significant Boston presence. A more general Boston area or specific current address if found: 300 Fifth Avenue, Waltham, MA 02451, USA is associated with their Boston lab.) Let's use Waltham: 300 Fifth Avenue, Waltham, MA 02451, USA
Provides specialized bioanalytical services to the numerous pharmaceutical and biotechnology companies in the US Northeast, offering local expertise and rapid project turnaround.
Address: 9955 Mesa Rim Rd, San Diego, CA 92121, USA
Caters to the specific needs of biotech and pharmaceutical companies in California and the wider Pacific region, offering local expertise and rapid turnaround times for cutting-edge therapeutic modalities.
Address: 31-37 W Thebarton Rd, Thebarton SA 5031, Australia
Supports the growing pharmaceutical and biotech research sector in Australia and the broader APAC region, leveraging Australia's favorable clinical trial environment and providing access to regional expertise.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, BioAgilytix' leadership includes:
BioAgilytix has been backed by several prominent investors over the years, including:
BioAgilytix has actively strengthened its leadership team over the past 12-18 months, with key C-suite appointments in People Operations and Commercial leadership to support its global growth and strategic objectives.
Discover the tools BioAgilytix uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
BioAgilytix commonly uses the email format of 'firstname.lastname@bioagilytix.com'. Variations such as 'firstinitiallastname@bioagilytix.com' may also exist.
[first].[last]@bioagilytix.com
Format
jane.doe@bioagilytix.com
Example
85%
Success rate
PR Newswire • August 1, 2023
BioAgilytix announced the appointment of Joe Principe to the role of Chief Commercial Officer, responsible for leading the company's global commercial organization and driving its growth strategy....more
PR Newswire • May 10, 2023
BioAgilytix announced the appointment of Anita Simkins as its new Chief People Officer (CPO). She will lead all aspects of human resources, focusing on talent strategy, organizational development, and company culture....more
Business Wire • March 2, 2023
BioAgilytix celebrated the grand opening of its new, larger laboratory facility in San Diego, California, significantly expanding its capacity to provide bioanalytical services, particularly for cell and gene therapies, to clients on the U.S. West Coast....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including BioAgilytix, are just a search away.